- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 15.02M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $164.85M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $168.6M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.98M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2.98M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $10.12M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $12.32M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $51.68M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $52.98M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $220.33M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $225.74M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $87.33M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $90.27M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $388.84M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $394.43M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 14.23M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $342K |
| Capex | Q1 2025 · Mar 31, 2024 | $177K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.03M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $182.69M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $183.97M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.13 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.13 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $19.4M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $10.69M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$1.85M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$588K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $41.76M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $84.12M |